226 related articles for article (PubMed ID: 8584997)
1. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Blann AD; Dobrotova M; Kubisz P; McCollum CN
Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
[TBL] [Abstract][Full Text] [Related]
2. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis.
Blann AD; McCollum CN
Thromb Haemost; 1994 Jul; 72(1):151-4. PubMed ID: 7526483
[TBL] [Abstract][Full Text] [Related]
3. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
4. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
6. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
7. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
8. Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment.
Brännström M; Jansson JH; Boman K; Nilsson TK
Thromb Haemost; 1995 Aug; 74(2):612-5. PubMed ID: 8584993
[TBL] [Abstract][Full Text] [Related]
9. Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease.
Koksch M; Zeiger F; Wittig K; Siegemund A; Reininger CB; Pfeiffer D; Ruehlmann C
Eur J Vasc Endovasc Surg; 2001 Feb; 21(2):147-54. PubMed ID: 11237788
[TBL] [Abstract][Full Text] [Related]
10. Endothelial marker proteins in hyperhomocysteinemia.
de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
[TBL] [Abstract][Full Text] [Related]
11. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.
van Kesteren PJ; Kooistra T; Lansink M; van Kamp GJ; Asscheman H; Gooren LJ; Emeis JJ; Vischer UM; Stehouwer CD
Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242
[TBL] [Abstract][Full Text] [Related]
12. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Blann AD; Lip GY; Beevers DG; McCollum CN
Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
[TBL] [Abstract][Full Text] [Related]
13. Endothelial perturbation in cystic fibrosis.
Romano M; Collura M; Lapichino L; Pardo F; Falco A; Chiesa PL; Caimi G; Davì G
Thromb Haemost; 2001 Dec; 86(6):1363-7. PubMed ID: 11776300
[TBL] [Abstract][Full Text] [Related]
14. Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis.
Blann AD; Faragher EB; McCollum CN
Blood Coagul Fibrinolysis; 1997 Oct; 8(7):383-90. PubMed ID: 9391718
[TBL] [Abstract][Full Text] [Related]
15. [Decreased plasma soluble P-selectin level in coronary sinus after successful coronary angioplasty in patients with unstable angina].
Doi N; Nishio K; Nakatani H; Hayashi T; Miyamoto S; Hashimoto T; Dohi K
J Cardiol; 1999 May; 33(5):251-6. PubMed ID: 10354952
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
[TBL] [Abstract][Full Text] [Related]
17. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell activation in cutaneous vasculitis.
Jurd KM; Stephens CJ; Black MM; Hunt BJ
Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemias and fibrinolysis.
Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell markers (vWF, t-PA and PAI-1) in the elderly.
Gaussem P; Levy C; Verny M; Anglés-Cano E
Thromb Haemost; 1994 Jul; 72(1):164-5. PubMed ID: 7974369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
